Procter & Gamble Health Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

5466.85

-36.15 (-0.66%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

5466.85

-36.15 (-0.66%)
15:49 Dec 20

Quality

77/100
High Financial Strength

Valuation

20/100
Expensive Valuation

Technical

58/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Jun 2021	Jun 2022	Jun 2023	Jun 2024	TTM 2024
Net Sales	1008.73	1114.41	1229.62	1151.26	1159.74
Operating Expenses +	762.71	846.73	904.94	845.26	828.36
Raw Material	310.28	344.55	358.99	329.69	309.29
Increase Decrease in Cost	4.54	-4.75	2.85	0.87	22.18
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	150.47	167.56	206.17	215.16	200.74
Miscellaneous Expenses	339.74	381.03	416.45	378.46	296.15
Operating Profit	246.02	267.68	324.68	306	331.38
Other Income	18.1	13.19	18.39	15.63	12.86
Depreciation	30.04	27.08	28.1	27.4	26.69
Interest	0.8	0.42	0.77	0.72	0.69
Profit before tax and exceptio..	233.28	253.37	314.2	293.51	316.86
Exceptional Items	0	0	0	-20.19	-20.19
PBT	233.28	253.37	314.2	273.32	337.05
Provision for Taxation	56.48	60.85	84.73	72.34	78.93
Net Profit	176.8	192.52	229.47	200.98	217.74
NET Profit after MI	0	0	0	0	0
EPS	107	116	138	133	131.11
Operating Profit Margin (%)	24.39	24.02	26.4	26.58	28.57
Net Profit Margin (%)	17.53	17.28	18.66	17.46	18.77

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	51.80	51.80	51.80	51.80	51.80
FII	6.60	6.40	6.20	7.60	7.40
MF	10.40	10.20	9.90	9.00	8.40
Public	26.70	27.20	28.20	27.90	28.50
Others	0.10	0.00	0.00	0.00	0.00
Others	4.40	4.40	3.90	3.70	3.90